| Literature DB >> 25244948 |
Wen Xiong, Yun Chen, Yu Wang, Jiaguo Liu.
Abstract
BACKGROUND: Duck viral hepatitis (DVH) is an acute disease of young ducklings with few convenient and effective veterinary drugs to treat. In pathology, present study mainly focused on the immune mechanism, but very few studies have concerned with the role of oxidative stress in the pathogenesis of DVH. To study the antioxidative and hepatoprotective effects of icariin and its phosphorylated derivative against DVH, we prepared phosphorylated icariin (p-icariin) using the sodium trimetaphosphate-sodium tripolyphosphate method. Ducklings were drunk with icariin and p-icariin after being challenged with duck hepatitis virus 1 (DHV-1). We recorded the number of dead ducklings, gross pathological changes in the liver, and changes in indices of oxidative stress and liver injury. The correlations between these indices were also analyzed.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25244948 PMCID: PMC4177705 DOI: 10.1186/s12917-014-0226-3
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Figure 1Visual assessment of liver pathology. (A) The livers of ducklings in the BC group are normal without pathological changes. (B) Extensive pathological changes can be seen in ducklings in the VC group, including fading of the liver color, swelling, and scattered hemorrhage. (E) Overt DVH is associated with opisthotonus. (C, D) Administration of icariin (C) or p-icariin (D) alleviates the pathological changes induced by DHV-1. The color of the livers in both groups is similar to those of the BC group. The extent of swelling is reduced and there are fewer hemorrhages in both groups, especially in the p-icariin group.
Survival rate
|
|
|
|
|
|---|---|---|---|
| Icariin | 30 | 6 | 20.0bc |
| P-icariin | 30 | 9 | 30.0b |
| VC | 30 | 0 | 0.0c |
| BC | 30 | 30 | 100.0a |
a–cValues within a column without the same superscripts (a–c) are significantly different (p < 0.05). bc with b and c were no significant differences.
Figure 2Plasma iNOS and MDA levels. a,bBars without the same superscripts (a,b) at the same time are significantly different (p < 0.05). ab with a and b were no significant differences.
Figure 3Plasma GSH-Px, SOD, and catalase levels. a,bBars without the same superscripts (a,b) at the same time are significantly different (p < 0.05). ab with a and b were no significant differences.
Indices of liver injury
|
| |||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| 4 | 12.000 ± 3.512b | 31.800 ± 3.987a | 15.000 ± 4.000b | 17.000 ± 1.414b | |
| ALT (IU/L) | 8 | 12.000 ± 1.000b | 24.750 ± 1.109a | 19.750 ± 4.922b | 18.500 ± 5.500b |
| 54 | 9.400 ± 2.112c | 49.200 ± 3.264a | 33.500 ± 0.500b | 30.333 ± 0.333b | |
| 4 | 23.750 ± 1.315b | 30.750 ± 3.816b | 49.800 ± 1.600a | 44.700 ± 2.563a | |
| AST (IU/L) | 8 | 24.750 ± 2.496b | 27.000 ± 1.577b | 48.600 ± 7.800a | 51.600 ± 6.158a |
| 54 | 25.000 ± 6.245b | 41.330 ± 4.667a | 51.000 ± 6.557a | 52.667 ± 8.930a | |
| 4 | 23.220 ± 1.458a | 17.220 ± 2.449b | 24.400 ± 1.203a | 21.670 ± 1.564ab | |
| TP (g/L) | 8 | 20.740 ± 0.627a | 17.060 ± 0.848b | 17.920 ± 1.498a | 20.440 ± 1.608a |
| 54 | 23.380 ± 0.711a | 15.820 ± 1.639b | 22.410 ± 1.559a | 19.100 ± 1.774ab | |
| 4 | 9.675 ± 0.731a | 7.987 ± 0.067a | 8.976 ± 0.635a | 9.090 ± 0.270a | |
| Albumin (g/L) | 8 | 8.833 ± 0.318a | 6.675 ± 0.217b | 6.360 ± 0.386b | 7.056 ± 0.851ab |
| 54 | 8.760 ± 0.328a | 5.267 ± 0.260c | 7.680 ± 0.705ab | 6.720 ± 0.413b | |
| 4 | 13.350 ± 0.235a | 12.200 ± 0.769a | 15.432 ± 0.574a | 13.464 ± 0.702ab | |
| Globulin (g/L) | 8 | 12.460 ± 0.304a | 13.080 ± 0.761a | 12.240 ± 1.043a | 13.392 ± 0.763a |
| 54 | 14.620 ± 0.461a | 11.300 ± 0.551c | 13.848 ± 0.794ab | 12.480 ± 0.317b | |
| 4 | 695.750 ± 35.172a | 713.250 ± 44.618a | 618.720 ± 51.188a | 612.480 ± 51.006a | |
| ALP (IU/L) | 8 | 613.000 ± 32.929a | 640.250 ± 18.400a | 624.160 ± 66.946a | 657.280 ± 65.141a |
| 54 | 659.000 ± 17.459b | 830.000 ± 41.540a | 651.400 ± 82.500b | 630.600 ± 38.259b | |
| 4 | 786.000 ± 61.093a | 849.000 ± 78.945a | 926.000 ± 36.865a | 814.200 ± 54.631a | |
| LDH (IU/L) | 8 | 561.000 ± 20.228a | 668.250 ± 29.565a | 692.200 ± 54.310a | 684.800 ± 50.258a |
| 54 | 613.400 ± 23.359c | 1024.66 ± 57.704a | 831.333 ± 67.814b | 758.500 ± 99.500bc | |
a-cValues within the same row without the same superscripts (a-c) are significantly different (p < 0.05). ab with a and b were no significant differences. bc with b and c were no significant differences.
Pearson’s correlation coefficients between indices of liver injury and oxidative stress
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GSH-Px | 1 | −0.775* | 0.510 | 0.398 | −0.773* | −0.637 | −0.048 | 0.759* | 0.631 | 0.697 | −0.401 | −0.708* |
| iNOS | 1 | −0.137 | 0.112 | 0.826* | 0.279 | −0.357 | −0.573 | −0.487 | −0.487 | 0.286 | 0.290 | |
| Catalase | 1 | 0.691 | −0.370 | −0.780* | −0.098 | 0.605 | 0.501 | 0.680 | −0.325 | −0.705 | ||
| SOD | 1 | −0.140 | −0.805* | −0.380 | 0.212 | 0.320 | 0.217 | −0.488 | −0.821* | |||
| MDA | 1 | 0.409 | −0.397 | −0.420 | −0.315 | −0.424 | 0.419 | 0.436 | ||||
| ALT | 1 | 0.445 | −0.642 | −0.779* | −0.574 | 0.256 | 0.966** | |||||
| AST | 1 | −0.310 | −0.501 | −0.202 | −0.435 | 0.479 | ||||||
| TP | 1 | 0.871** | 0.943** | 0.084 | −0.604 | |||||||
| Albumin | 1 | 0.696 | 0.054 | −0.749* | ||||||||
| Globulin | 1 | 0.149 | −0.497 | |||||||||
| ALP | 1 | 0.362 | ||||||||||
| LDH | 1 |
*p < 0.05.
**p < 0.01.